Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
CompletedOBSERVATIONAL
Enrollment
40
Participants
Timeline
Start Date
April 30, 2003
Primary Completion Date
May 31, 2004
Study Completion Date
December 31, 2005
Conditions
Rheumatoid Arthritis
Interventions
DRUG
response to infliximab associated with methotrexate
Trial Locations (1)
76031
CHU de Rouen - Hôpitaux de Rouen, Rouen
All Listed Sponsors
lead
University Hospital, Rouen
OTHER
NCT00213564 - Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter